The purpose of this study is the randomized blind research of the assessment of the different levels of glycemia during Coronary Artery Bypass Graft (CABG) with cardiopulmonary by-pass (CPB) between clonidine and placebo. As clonidine decrease the inflammatory response during cardiac surgery, the investigators would like to know if the glycemia levels in clondine group will be lower than placebo group.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
46
bolus, clonidine 2 mg/kg IV
1 ML ringer lactato IV, as placebo
National institut of Cardiology
Rio de Janeiro, Rio de Janeiro, Brazil
sedation
Clonidine 2 mg/kg IV. assessment sedation with Ransay scale
Time frame: 2 years
Glycemia
clonide 2 mg/kg. assessment the glycemia during CPB.
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.